Carboplatin +/− Topotecan Ophthalmic Artery Chemosurgery for Intraocular Retinoblastoma

• Jasmine H. Francis ,

  * E-mail: francij1@mskcc.org

  Affiliation Ophthalmic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Y. Pierre Gobin,

  Affiliation Service of Interventional Neuroradiology, Departments of Neurosurgery Neurology and Radiology, Weill Cornell Medical College of New York Presbyterian Hospital, New York, New York, United States of America

  ⨯
• Ira J. Dunkel,

  Affiliations Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America, Department of Pediatrics, Weill Cornell Medical College, New York, New York, United States of America

  ⨯
• Brian P. Marr,

  Affiliations Ophthalmic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America, Department of Ophthalmology, Weill Cornell Medical College, New York, New York, United States of America

  ⨯
• Scott E. Brodie,

  Affiliations Ophthalmic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America, Department of Ophthalmology, Mount Sinai School of Medicine, New York, New York, United States of America

  ⨯
• Gowtham Jonna,

  Affiliation Ophthalmic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• David H. Abramson

  Affiliations Ophthalmic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America, Department of Ophthalmology, Weill Cornell Medical College, New York, New York, United States of America

  ⨯